Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Freedom from disease activity in multiple sclerosis.
Cystoid macular oedema after fingolimod treatment in multiple sclerosis.
[Change of treatment in patients with multiple sclerosis and its consequences in clinical practice].
Pathology of Multiple Sclerosis.
Carnitine for fatigue in multiple sclerosis.
Visual evoked potentials in early diagnosis of demyelinating diseases - a case report of Devic's disease.
Viruses and Multiple Sclerosis.
Targeting NOX enzymes in the central nervous system: therapeutic opportunities.
Multiple sclerosis: Phases of disease improvement unrelated to relapses.
The changing clinical course of multiple sclerosis: A matter of grey matter.
Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis.
Bayesian inferences for beta semiparametric-mixed models to analyze longitudinal neuroimaging data.
Review series on immune responses in neurodegenerative diseases: Oligodendrocyte-microglia cross-talk in the CNS.
Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord.
Generation and characterization of spiking and non-spiking oligodendroglial progenitor cells from embryonic stem cells.
Demyelinating disease in SLE: Is it multiple sclerosis or lupus?
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy.
[Association between polymorphisms of cytokine genes and the rate of multiple sclerosis progression.]
Pattern of Uveitis in an Egyptian Population with Multiple Sclerosis: A Hospital-Based Study.
Protective Effects of 7,8-Dihydroxyflavone on Retinal Ganglion and RGC-5 Cells Against Excitotoxic and Oxidative Stress.
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses.
Natalizumab Therapy for Multiple Sclerosis.
Polymorphisms of paraoxonase 1 and 2 genes and the risk of multiple sclerosis in the Polish population.
Atomic structures of amyloid cross-beta spines reveal varied steric zippers.
Pages
« first
‹ previous
…
243
244
245
246
247
248
249
250
251
…
next ›
last »